It showed that patients with PNPLA3-associated steatohepatitis show better improvement of hepatic steatosis after MBS as compared to carriers of PNPLA3 wild-type alleles; consequently, PNPLA3 rs738409 is a good prognostic factor for MASLD patients undergoing MBS. This evidence concerns the gene PNPLA3 and fatty liver disease.